标题
Radiopharmaceutical therapy in cancer: clinical advances and challenges
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-30
DOI
10.1038/s41573-020-0073-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Imaging the Distribution of Gastrin Releasing Peptide Receptors in Cancer
- (2020) Lucia Baratto et al. JOURNAL OF NUCLEAR MEDICINE
- Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy
- (2020) Urs B. Hagemann et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Time for radioimmunotherapy: an overview to bring improvements in clinical practice
- (2019) O. Leaman Alcibar et al. Clinical & Translational Oncology
- Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples
- (2019) Clément Morgat et al. PLoS One
- Radionuclide Therapy of Metastatic Prostate Cancer
- (2019) Clemens Kratochwil et al. SEMINARS IN NUCLEAR MEDICINE
- Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated 177Lu-Labeled Folic Acid Using SPECT/CT Imaging of Mice
- (2019) Arun Gupta et al. MOLECULAR PHARMACEUTICS
- Preclinical investigation of 212Pb-DOTAMTATE for peptide receptor radionuclide therapy in a neuroendocrine tumor model.
- (2019) Tania A Rozgaja Stallons et al. MOLECULAR CANCER THERAPEUTICS
- Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit
- (2019) Alberto Dalla Volta et al. EUROPEAN UROLOGY
- Alpha particle Radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial
- (2019) Vivek Subbiah et al. CLINICAL CANCER RESEARCH
- Mesothelin-targeted thorium-227 conjugate (MSLN-TTC): Preclinical evaluation of a new targeted alpha therapy for mesothelin-positive cancers
- (2019) Urs B Hagemann et al. CLINICAL CANCER RESEARCH
- Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials
- (2019) Jongho Jeon INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Decreased fracture rate by mandating bone-protecting agents in the EORTC 1333/PEACE III trial comparing enzalutamide and Ra223 versus enzalutamide alone: An interim safety analysis.
- (2019) Bertrand F. Tombal et al. JOURNAL OF CLINICAL ONCOLOGY
- Bispecific Radioligands targeting Prostate Specific Membrane Antigen (PSMA) and Gastrin Releasing Peptide receptors (GRPr) on the surface of prostate cancer cells
- (2019) Christos Liolios et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy
- (2019) Hans-Jürgen Wester et al. SEMINARS IN NUCLEAR MEDICINE
- [124I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors
- (2019) Lance T. Hall et al. MOLECULAR IMAGING AND BIOLOGY
- Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
- (2019) Ayman Abouzayed et al. Pharmaceutics
- Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177 Lu-Satoreotide Tetraxetan
- (2019) Diane Reidy-Lagunes et al. CLINICAL CANCER RESEARCH
- Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma
- (2019) Ryan D Cassaday et al. CLINICAL CANCER RESEARCH
- Rapid Reduction of Peripheral Blasts in Older Patients with Refractory Acute Myeloid Leukemia (AML) Using Re-Induction with Single Agent Anti-CD45 Targeted Iodine (131I) Apamistamab [Iomab-B] Radioimmunotherapy in the Phase III SIERRA Trial
- (2019) Benjamin K. Tomlinson et al. Clinical Lymphoma Myeloma & Leukemia
- Peptide Receptor Radiotherapy: Current Approaches and Future Directions
- (2019) Grace Kong et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer
- (2019) Jens Kurth et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Bombesin receptors as potential targets for anticancer drug delivery and imaging
- (2019) Deep Pooja et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with Radium-223: The Role of Bystander Effects and their Potential for Therapy
- (2019) Calvin N Leung et al. JOURNAL OF NUCLEAR MEDICINE
- Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations
- (2019) Klaudia Siwowska et al. Pharmaceutics
- Therapeutic Applications of Pretargeting
- (2019) Verhoeven et al. Pharmaceutics
- Phase 1, Open-Label, Dose Escalation Study of I-131-CLR1404 (CLR 131) in Patients with Relapsed or Refractory Multiple Myeloma
- (2019) Jarrod Longcor et al. BLOOD
- Mathematical Modeling of Pre-Clinical Alpha-Emitter Radiopharmaceutical Therapy
- (2019) Alireza Karimian et al. CANCER RESEARCH
- Radium-223 mechanism of action: implications for use in treatment combinations
- (2019) Michael J. Morris et al. Nature Reviews Urology
- Targeted Alpha-Particle Therapy for Hematologic Malignancies
- (2019) Joseph G. Jurcic SEMINARS IN NUCLEAR MEDICINE
- Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
- (2019) Stefanie Hammer et al. CLINICAL CANCER RESEARCH
- Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy
- (2019) A.G. Arranja et al. Materials Science & Engineering C-Materials for Biological Applications
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
- (2018) Jonathan Strosberg et al. JOURNAL OF CLINICAL ONCOLOGY
- [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
- (2018) Michael S Hofman et al. LANCET ONCOLOGY
- Current approaches to incorporation of radium-223 in clinical practice
- (2018) Chris Parker et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Radiation Imagers for Quantitative, Single-particle Digital Autoradiography of Alpha- and Beta-particle Emitters
- (2018) Brian W. Miller SEMINARS IN NUCLEAR MEDICINE
- [ 177 Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer
- (2018) Kambiz Rahbar et al. LANCET ONCOLOGY
- Radiotherapy in the Treatment of Primary Osteosarcoma – a Single Center Experience
- (2018) Susanne Oertel et al. TUMORI
- Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study
- (2018) Ravit Geva et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radioactive drugs emerge from the shadows to storm the market
- (2018) Elie Dolgin NATURE BIOTECHNOLOGY
- Targeted Alpha Therapy, an Emerging Class of Cancer Agents
- (2018) et al. JAMA Oncology
- Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma
- (2017) Richard B Noto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog
- (2017) Dana C. Baiu et al. JOURNAL OF NUCLEAR MEDICINE
- Resin Versus Glass Microspheres for 90 Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry
- (2017) Axel Van Der Gucht et al. JOURNAL OF NUCLEAR MEDICINE
- Somatostatin Receptor Antagonists for Imaging and Therapy
- (2017) Melpomeni Fani et al. JOURNAL OF NUCLEAR MEDICINE
- Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
- (2017) Klaus Kopka et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted radionuclide therapy in combined-modality regimens
- (2017) Martin R Gill et al. LANCET ONCOLOGY
- Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors
- (2017) Lucia Baratto et al. MOLECULAR IMAGING AND BIOLOGY
- Metal-Based PSMA Radioligands
- (2017) Eleni Gourni et al. MOLECULES
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
- (2017) Cindy J. Choy et al. Theranostics
- Phase I trial of the targeted alpha-particle nano-generator actinium-225 (225Ac-lintuzumab) (anti-CD33; HuM195) in acute myeloid leukemia (AML).
- (2017) J. G. Jurcic et al. JOURNAL OF CLINICAL ONCOLOGY
- Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study
- (2016) S. Modak et al. JOURNAL OF NUCLEAR MEDICINE
- 68 Ga/ 177 Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
- (2016) Simone U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted -Particle Radiopharmaceutical Therapy
- (2016) A. P. Kiess et al. JOURNAL OF NUCLEAR MEDICINE
- 225Ac-PSMA-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres
- (2016) Derek M. Biederman et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer
- (2016) Jianting Yue et al. MEDICAL PHYSICS
- Current use of PSMA–PET in prostate cancer management
- (2016) Tobias Maurer et al. Nature Reviews Urology
- Biologic and Clinical Perspectives on Thyroid Cancer
- (2016) James A. Fagin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma
- (2016) Sally L. George et al. NUCLEAR MEDICINE COMMUNICATIONS
- Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
- (2016) Lisa Bodei et al. SEMINARS IN NUCLEAR MEDICINE
- Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma
- (2016) Lilian Schwarz et al. WORLD JOURNAL OF SURGERY
- Targeting folate receptor alpha for cancer treatment
- (2016) Anthony Cheung et al. Oncotarget
- Comparison between Three Promising ß-emitting Radionuclides, 67Cu, 47Sc and 161Tb, with Emphasis on Doses Delivered to Minimal Residual Disease
- (2016) Christophe Champion et al. Theranostics
- Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival
- (2015) Geert Maleux et al. ACTA ONCOLOGICA
- A case report of image-based dosimetry of bone metastases with Alpharadin (223Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up
- (2015) Massimiliano Pacilio et al. ANNALS OF NUCLEAR MEDICINE
- Lutetium-177 Therapeutic Radiopharmaceuticals: Linking Chemistry, Radiochemistry, and Practical Applications
- (2015) Sharmila Banerjee et al. CHEMICAL REVIEWS
- Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities
- (2015) Zora Novakova et al. FEBS Journal
- Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
- (2015) A. P. Kiess et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy
- (2015) M. Ljungberg et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative single-particle digital autoradiography with α -particle emitters for targeted radionuclide therapy using the iQID camera
- (2015) Brian W. Miller et al. MEDICAL PHYSICS
- Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems
- (2015) Zachary S. Morris et al. RADIOTHERAPY AND ONCOLOGY
- Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
- (2014) Raya Mawad et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Radiopharmaceutical therapy in the era of precision medicine
- (2014) George Sgouros et al. EUROPEAN JOURNAL OF CANCER
- Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
- (2014) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
- (2014) Christian M. Zechmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumor-Absorbed Dose Predicts Progression-Free Survival Following 131I-Tositumomab Radioimmunotherapy
- (2014) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 25: MIRDcell V2.0 Software Tool for Dosimetric Analysis of Biologic Response of Multicellular Populations
- (2014) B. Vaziri et al. JOURNAL OF NUCLEAR MEDICINE
- Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy
- (2014) J. P. Weichert et al. Science Translational Medicine
- Dosimetry for Radiopharmaceutical Therapy
- (2014) George Sgouros et al. SEMINARS IN NUCLEAR MEDICINE
- Side Effects of Yttrium-90 Radioembolization
- (2014) Ahsun Riaz et al. Frontiers in Oncology
- Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model
- (2013) J. J. Orozco et al. BLOOD
- Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
- (2013) Cristina Müller et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
- (2013) Reineke A. Schoot et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications
- (2013) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases
- (2012) Jatinder Goyal et al. CANCER LETTERS
- Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
- (2012) C. Barinka et al. CURRENT MEDICINAL CHEMISTRY
- Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma
- (2012) S. Senthamizhchelvan et al. JOURNAL OF NUCLEAR MEDICINE
- DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted 177Lu-Radionuclide Tumor Therapy in Mice
- (2012) C. Muller et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy
- (2012) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
- (2012) Maarten LJ Smits et al. LANCET ONCOLOGY
- A dose point kernel database using GATE Monte Carlo simulation toolkit for nuclear medicine applications: Comparison with other Monte Carlo codes
- (2012) Panagiotis Papadimitroulas et al. MEDICAL PHYSICS
- A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical
- (2012) Jaime Simón et al. NUCLEAR MEDICINE AND BIOLOGY
- Why are investors not interested in my radiotracer? The industrial and regulatory constraints in the development of radiopharmaceuticals
- (2012) Richard G. Zimmermann NUCLEAR MEDICINE AND BIOLOGY
- A bone marrow toxicity model for223Ra alpha-emitter radiopharmaceutical therapy
- (2012) Robert F Hobbs et al. PHYSICS IN MEDICINE AND BIOLOGY
- Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma
- (2011) I. Frank Ciernik et al. CANCER
- Radiopeptide Imaging and Therapy in Europe
- (2011) V. Ambrosini et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor targeting using 67Ga-DOTA-Bz-folate — investigations of methods to improve the tissue distribution of radiofolates
- (2011) Cristina Müller et al. NUCLEAR MEDICINE AND BIOLOGY
- A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent
- (2011) Jessie R. Nedrow-Byers et al. PROSTATE
- Transcatheter Intraarterial Therapies: Rationale and Overview
- (2011) Robert J. Lewandowski et al. RADIOLOGY
- Low-Dose Iodine-131 Metaiodobenzylguanidine Therapy for Patients With Malignant Pheochromocytoma and Paraganglioma
- (2010) Mark Shilkrut et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Yttrium-90 DOTATOC therapy in GEP-NET and other SST2 expressing tumors: a selected review
- (2010) Lutfun Nisa et al. ANNALS OF NUCLEAR MEDICINE
- Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand?
- (2010) Eleni Liapi et al. ANNALS OF SURGICAL ONCOLOGY
- Sequential Cytarabine and -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
- (2010) T. L. Rosenblat et al. CLINICAL CANCER RESEARCH
- Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer
- (2010) Walter Jentzen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues
- (2010) Søren M. Bentzen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy
- (2010) Robert F. Hobbs et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
- (2010) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy
- (2010) H. Amro et al. JOURNAL OF NUCLEAR MEDICINE
- The -Camera: A Quantitative Digital Autoradiography Technique Using a Charge-Coupled Device for Ex Vivo High-Resolution Bioimaging of -Particles
- (2010) T. Back et al. JOURNAL OF NUCLEAR MEDICINE
- MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of -Particle Emitters for Targeted Radionuclide Therapy
- (2010) G. Sgouros et al. JOURNAL OF NUCLEAR MEDICINE
- Folic Acid Conjugates for Nuclear Imaging of Folate Receptor-Positive Cancer
- (2010) C. Muller et al. JOURNAL OF NUCLEAR MEDICINE
- Radioimmunotherapy of Solid Tumors: Searching for the Right Target
- (2010) Hong Song et al. Current Drug Delivery
- Adjuvant Intra-arterial Iodine-131-labeled Lipiodol for Resectable Hepatocellular Carcinoma
- (2009) Wan Yee Lau et al. ANNALS OF SURGERY
- 131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma
- (2009) A. K. Gopal et al. BLOOD
- Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2009) J. M. Pagel et al. BLOOD
- Radiation Dosimetry, Pharmacokinetics, and Safety of Ultratrace™ Iobenguane I-131 in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid
- (2009) R. Edward Coleman et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
- (2009) Sara Gonias et al. JOURNAL OF CLINICAL ONCOLOGY
- MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry--Standardization of Nomenclature
- (2009) W. E. Bolch et al. JOURNAL OF NUCLEAR MEDICINE
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- Internal radiotherapy using 32P colloid or microsphere for refractory solid tumors
- (2008) Wen Gao et al. ANNALS OF NUCLEAR MEDICINE
- Pseudoirreversible Inhibition of Prostate-Specific Membrane Antigen by Phosphoramidate Peptidomimetics†
- (2008) Tiancheng Liu et al. BIOCHEMISTRY
- Antibody-targeted liposomes in cancer therapy and imaging
- (2008) Stavroula Sofou et al. Expert Opinion on Drug Delivery
- First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX Plus125IUdR
- (2008) C. Rebischung et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy
- (2008) B. W. Wessels et al. JOURNAL OF NUCLEAR MEDICINE
- Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting
- (2008) R. Cescato et al. JOURNAL OF NUCLEAR MEDICINE
- International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States
- (2008) R. T. Jensen et al. PHARMACOLOGICAL REVIEWS
- Three-Dimensional Imaging-Based Radiobiological Dosimetry
- (2008) George Sgouros et al. SEMINARS IN NUCLEAR MEDICINE
- Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy
- (2008) Xiao-Ming Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started